Roivant Sciences Ltd Financial Flexibility Index
Roivant Sciences Ltd financial flexibility index. Roivant Sciences Ltd (ROIV) has a Financial Flexibility Index of -0.76x as of December 2025. Free cash flow of $-191.55 Million (operating CF $-196.48 Million minus capex $4.93 Million) represents -1% of total liabilities ($251.14 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Roivant Sciences Ltd (2019–2025)
Financial flexibility index of Roivant Sciences Ltd from 2019 to 2025. Historical Financial Flexibility Index trend for Roivant Sciences Ltd across 7 annual periods. Check Roivant Sciences Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Roivant Sciences Ltd Financial Flexibility Index by Year (2019–2025)
Roivant Sciences Ltd financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Roivant Sciences Ltd. For the full cash flow conversion analysis, see ROIV cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.34x | $-834.85 Million | $-839.45 Million | $249.74 Million | ▼ -238.7% |
| 2024 | -0.99x | $-763.89 Million | $-765.27 Million | $773.95 Million | ▲ +7.1% |
| 2023 | -1.06x | $-830.70 Million | $-843.39 Million | $782.02 Million | ▲ +15.7% |
| 2022 | -1.26x | $-660.29 Million | $-677.73 Million | $523.70 Million | ▼ -21.8% |
| 2021 | -1.04x | $-546.33 Million | $-552.14 Million | $527.69 Million | ▲ +49.6% |
| 2020 | -2.05x | $-756.92 Million | $-761.83 Million | $368.36 Million | ▲ +8.6% |
| 2019 | -2.25x | $-1.01 Billion | $-1.02 Billion | $450.51 Million | — |